Author:
Ito Yumi,Narita Norihiko,Nomi Nozomi,Sugimoto Chizuru,Takabayashi Tetsuji,Yamada Takechiyo,Karaya Kazuhiro,Matsumoto Hideki,Fujieda Shigeharu
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Cooper, J. S. et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350, 1937–1944 (2004).
2. Bernier, J. et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350, 1945–1952 (2004).
3. Galluzzi, L. et al. Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869–1883 (2012).
4. Hamaguchi, K. et al. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 53, 5225–5232 (1993).
5. Xu, Z. Y., Loignon, M., Han, F. Y., Panasci, L. & Aloyz, R. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation and reduced apoptosis. J Pharmacol Exp Ther 314, 495–505 (2005).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献